ARCHIVES

Genitope Therapy In Phase III Trials For Low-Grade B-Cell Non-Hodgkin’s.

This article is from The Cancer Letter archive.

Vol. 27 No. 39 | October 26, 2001

Download PDF Visit The Full Archive

Related Articles

Drug Development Gets Extra $500,000

November 18, 1977

Battelle Wins Big Toxiology Contract

March 22, 1974

Court Upholds FDA Position On Definition Of A Drug.

February 23, 2001

President Obama Signs Spending Bill Giving NCI 2.8 Percent Increase

December 18, 2009

AZT, DDC Combination Increase CD4 Counts, NIAID Trial Finds

January 17, 1992

New Test Predicts Breast Cancer Recurrence And Who Benefits Most From Chemotherapy

December 31, 2004